1482 Metformin 1000mg (Prolonged release) and Glimepiride 3mg Tablets IP

Metformin 1000mg (Prolonged release) and Glimepiride 3mg Tablets IP are designed for effective glycemic control in patients with type 2 diabetes. The unique combination offers dual action—Metformin helps reduce glucose production in the liver, while Glimepiride stimulates insulin release. This once-daily formulation provides consistent blood sugar management and improved patient compliance.